The USPTO is required by the America Invents Act ("AIA") to study and report on ways of providing independent, confirming genetic diagnostic tests where gene patients and exclusive licensing for primary genetic diagnostic tests exist.  In an effort to gather information, the USPTO is hosting two hearings:

1. Thursday, February 16, 2012 at 9 AM, Eastern Standard Time, in Alexandria, Virginia; and

2. Friday, March 9, 2012 at 9 AM, Pacific Standard Time, in San Diego, California.

The public is invited to give testimony at the hearings and/or submit written comments.  For more information, including how to share input with the agency, please access the following link in the Federal Register (77 Fed. Reg. 3748, January 25, 2012):